Great meeting our colleagues from Centre for Psychedelic Research and UCL SAP at the Horizons Conference Horizons PBC!

CPCR Faculty David Yaden (David B. Yaden) and Researcher Marianna Graziosi (@MariannaGrazz) presented on the effects of psilocybin on worldview at the University of Pennsylvania at a meeting on primal worldview beliefs Primals Project, led by Jer Clifton

In an analysis of our randomized trial of psilocybin assisted therapy for MDD, we found that stronger therapeutic alliance was associated with improvements in depression up to one year later. Additionally, stronger alliance prior to psilocybin administration (after rapport with

Our prospective survey on belief changes following psilocybin use is now published with David B. Yaden AlChemical77 Sydney White and others.

researchgate.net/publication/38…

See link to preprint explainer thread below

Congratulations to Dr. Fred Barrett (Fred Barrett) who was named the Oliver Lee McCabe III, Ph.D. Professor in the Neuropsychopharmacology of Consciousness!

An endowed professorship is a distinct honor in academia and is a testament to Dr. Barrett's hard work, leadership, and

CPCR Director, Dr. Fred Barrett Fred Barrett, was interviewed by Oprah Daily on the state of #psychedelics
oprahdaily.com/life/health/a4…

Can psilocybin assisted therapy reduce opioid use and improve quality of life?

We are seeking people near Baltimore, Maryland with Opioid Use Disorder to participate in a trial to see if psilocybin can reduce opioid use and improve quality of life. Volunteers must be between the

New NIH NCCIH study launching: Psilocybin and Affective Function in Chronic Low Back Pain and Depression (CLBP+D). Me & Patrick Finan are Co-PIs.

CLPB+D is among the leading causes of disability in the US.

Now recruiting! Please spread the word and/or send ideas for study recruitment.

Following its recent publication in the American Journal of Bioethics, today the Hub at Oxford for Psychedelic Ethics (HOPE) launches the Hopkins-Oxford Psychedelic Ethics Consensus Statement at HOPE-statement.com. 🧵:

This article attempts to quantify the risks and benefits of psychedelics and considers how they may change in the future as better designed studies with larger and more heterogenous samples emerge. The early state of this research calls for caution about predicting the long-term

🚨 Launching recruitment for a NEW clinical trial

We are seeking individuals with chronic low back pain and co-occurring depression to participate in a psychedelic study, investigating whether psilocybin can help!

Learn more and apply at hopkinspsychedelic.org/backpain

It was such a pleasure to work with Julia Sarah Rohde, Praachi Tiwari, Jed Siev, & @existwell on a comprehensive systematic review of the literature on psychedelics, OCD, and related disorders. Here's what we found! (... a 🧵).

Welcome Luna Crowley to the CPCR! Luna recently graduated from Northern Vermont University where she studied holistic health, chemistry, and anthropology. She is now studying the therapeutic effects of psilocybin in alcohol use disorder and depression, under the guidance of Dr.

We’re hiring! Visit hopkinspsychedelic.org/employment to apply!

CPCR researchers recently published a systematic review of psychedelics and #OCD & related disorders. Led Marianna Graziosi with Julia Rohde, Praachi Tiwari, Jed Siev, and David B. Yaden. Open access link here: authors.elsevier.com/c/1ivoP7spc4mu…

Researchers at the Johns Hopkins Center for Psychedelic & Consciousness Research (CPCR) are seeking volunteers for a 5-10 minute survey study about psychedelic experiences among veterans. They are particularly interested in veterans with therapy/medicine experience(s) with

Curious about psychedelics for cognitive impairment, dementia, and Alzheimer’s disease? Dr. Albert Garcia-Romeu (AlChemical77) tells us all about it in his interview with The Microdose:
themicrodose.substack.com/p/cognitive-im…

If you are interested in learning more or applying for our study of

CPCR Faculty David Yaden (David B. Yaden) wrote an essay with relevance to psychedelic research - “William James was right about our strange inner experiences: Rather than Freud’s cynicism or Jung’s enthusiasm, we need an inquisitive approach to unusual forms of consciousness”. Check

Psychedelic experiences have real risks in recreational settings and adverse events can and do occur even in research and clinical contexts. While this information was primary for decades, the press around the positive potential of psychedelics in recent years leads us to issues